Bekker, L.G., Das, M., Abdool Karim, Q., Ahmed, K., Batting, J., Brumskine, W., Gill, K., Harkoo, I., Jaggernath, M., Kigozi, G. and Kiwanuka, N., 2024. Twice-yearly lenacapavir or daily F/TAF for HIV prevention in cisgender women. New England Journal of Medicine, 391(13), pp.1179-1192.
Twice-Yearly Lenacapavir or Daily F/TAF for HIV Prevention in Cisgender Women.
- Journal Articles
